<table id="table8" width="100%" xmlns="urn:hl7-org:v3" xmlns:v="http://validator.pragmaticdata.com/result" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8: Raltegravir Steady State Pharmacokinetic Parameters Following Administration of Recommended Doses</caption>
<col align="center" valign="bottom" width="20%"></col>
<col align="center" valign="bottom" width="16%"></col>
<col align="center" valign="bottom" width="18%"></col>
<col align="center" valign="bottom" width="8%"></col>
<col align="center" valign="bottom" width="19%"></col>
<col align="center" valign="bottom" width="19%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule">Age</th>
<th stylecode="Rrule">Formulation</th>
<th stylecode="Rrule">Dose</th>
<th stylecode="Rrule">N<footnote id="table8a">Number of patients with intensive pharmacokinetic (PK) results at the final recommended dose.</footnote>
</th>
<th stylecode="Rrule">Geometric Mean<content stylecode="italics">
<br/>(%CV)</content>
<br/>AUC<sub>0-12hr</sub> (µM∙hr)</th>
<th stylecode="Rrule">Geometric Mean<content stylecode="italics">
<br/>(%CV)</content>
<br/>C<sub>12hr</sub> (nM)</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">12 to 18 years</td>
<td stylecode="Rrule">Film-coated tablet</td>
<td stylecode="Rrule">400 mg twice daily, regardless of weight<footnote id="table8b">Patients in this age group received approximately 8 mg/kg/dose at time of intensive PK which met PK and safety targets. Based on review of the individual profiles and receipt of a mean dose of 390 mg, 400 mg twice daily was selected as the recommended dose for this age group.</footnote>
</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">15.7 (<content stylecode="italics">98</content>%)</td>
<td stylecode="Rrule">333 (<content stylecode="italics">78</content>%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">6 to less than 12 years</td>
<td stylecode="Rrule">Film-coated tablet</td>
<td stylecode="Rrule">400 mg twice daily, for patients ≥25 kg</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">15.8 (<content stylecode="italics">120</content>%)</td>
<td stylecode="Rrule">246 (<content stylecode="italics">221</content>%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">6 to less than 12 years</td>
<td stylecode="Rrule">Chewable tablet</td>
<td stylecode="Rrule">Weight based dosing, see<linkhtml href="#table1"> Table 1</linkhtml>
</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">22.6 (<content stylecode="italics">34</content>%)</td>
<td stylecode="Rrule">130 (<content stylecode="italics">88</content>%)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">2 to less than 6 years</td>
<td stylecode="Rrule">Chewable tablet</td>
<td stylecode="Rrule">Weight based dosing, see<linkhtml href="#table1"> Table 1</linkhtml>
</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">18.0 (<content stylecode="italics">59</content>%)</td>
<td stylecode="Rrule">71 (<content stylecode="italics">55</content>%)</td>
</tr>
</tbody>
</table>